Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
NCT00948311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 279
Last updated 2016-02-19
Summary
The purpose of this study is to develop and validate a survey instrument to be used by persons with type 1 diabetes aged 12 and older to screen for an eating disorder.
Conditions
- Type 1 Diabetes
- Eating Disorder
Sponsors & Collaborators
-
International Diabetes Center at Park Nicollet
collaborator OTHER -
Park Nicollet Eating Disorder Institute
collaborator OTHER -
Park Nicollet Foundation
collaborator OTHER -
HealthPartners Institute
lead OTHER
Principal Investigators
-
Margaret Powers, PhD · International Diabetes Center at Park Nicollet
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Optimising Health in Type 1 Diabetes
NCT02903615 ·Status: COMPLETED ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Liraglutide in Type 1 Diabetes
NCT01612468 ·Status: COMPLETED ·Phase: PHASE4
-
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
NCT07313384 ·Status: RECRUITING
-
Liraglutide as add-on to Insulin in Type 1 Diabetes
NCT02092896 ·Status: COMPLETED ·Phase: PHASE3
-
Individualised Postprandial Glucose Responses in Type 1 Diabetes
NCT05231642 ·Status: COMPLETED ·Phase: NA
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
NCT05713448 ·Status: RECRUITING
-
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441 ·Status: COMPLETED ·Phase: NA
-
Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 Diabetes
NCT01069393 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NCT04118374 ·Status: COMPLETED ·Phase: NA
-
Intermittent Fasting in Adults With Type 1 Diabetes
NCT06134986 ·Status: COMPLETED ·Phase: NA
-
Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
NCT00200018 ·Status: COMPLETED ·Phase: NA
-
Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet
NCT00118937 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 ·Status: COMPLETED ·Phase: PHASE2
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669 ·Status: RECRUITING
-
Inpatient Diabetes on Corticosteroids
NCT01970241 ·Status: COMPLETED ·Phase: PHASE4
-
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
NCT06105931 ·Status: RECRUITING ·Phase: PHASE1
-
Liraglutide in Type 1 Diabetes
NCT01722240 ·Status: COMPLETED ·Phase: PHASE3
-
Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
NCT07285330 ·Status: RECRUITING
-
Glucose Variability in Subclinical Hypertrophy
NCT02748434 ·Status: TERMINATED ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
Carbohydrates Under Target for Type 1 Diabetes Management
NCT04758858 ·Status: WITHDRAWN ·Phase: NA
-
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
NCT01299012 ·Status: COMPLETED